Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jia-Xing Zhao
Serum CA19-9 as a Marker of Circulating Tumor Cells in First Reflux Blood of Colorectal Cancer Patients
Oncotarget
Oncology
Related publications
Circulating miR-1826 in Plasma Correlates With Circulating Tumor Cells and Is a Prognostic Marker in Colorectal Cancer
Tumor Biology
Medicine
Cancer Research
Investigation of Unexpected Serum CA19-9 Elevation in Lewis-Negative Cancer Patients
Annals of Clinical Biochemistry
Medicine
Clinical Biochemistry
A Multicenter Pilot Study Examining the Role of Circulating Tumor Cells as a Blood-Based Tumor Marker in Patients With Extensive Small-Cell Lung Cancer
Frontiers in Oncology
Cancer Research
Oncology
Tumor-Infiltrating Immune Cells Act as a Marker for Prognosis in Colorectal Cancer
Frontiers in Immunology
Allergy
Immunology
Evaluation of Serum CEA and CA19-9 Levels as Prognostic Factors in Patients With Gastric Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Circulating Cell-Free High Mobility Group AT-hook 2 mRNA as a Detection Marker in the Serum of Colorectal Cancer Patients
Journal of Clinical Laboratory Analysis
Allergy
Immunology
Biochemistry
Public Health
Medical Laboratory Technology
Clinical Biochemistry
Hematology
Microbiology
Environmental
Occupational Health
SELEX Aptamer Used as a Probe to Detect Circulating Tumor Cells in Peripheral Blood of Pancreatic Cancer Patients
PLoS ONE
Multidisciplinary
Promoter Methylation of TRIM9 as a Marker for Detection of Circulating Tumor DNA in Breast Cancer Patients
SpringerPlus
Multidisciplinary
KRAS Mutation Analysis of Single Circulating Tumor Cells From Patients With Metastatic Colorectal Cancer
BMC Cancer
Cancer Research
Oncology
Genetics